Blueprint Medicines Corporation (BPMC) Covered Calls
Blueprint Medicines Corpis a biopharmaceutical company. It is focused on improving the lives of patients with genomically defined diseases driven by abnormal kinase activation.
There are no covered calls available for Blueprint Medicines Corporation.
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Blueprint Medicines Corp. is a biopharmaceutical company, which engages in developing of kinase inhibitors for genomically defined subsets of cancer patients. It has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling the development of potent highly selective compounds against clear genomic driver targets. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.
| Top 10 Open Interest For Aug 15 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | TSLA covered calls | 1. | MBX covered calls | |
| 2. | SLV covered calls | 7. | GLD covered calls | 2. | DLO covered calls | |
| 3. | SPY covered calls | 8. | AMZN covered calls | 3. | AAP covered calls | |
| 4. | IWM covered calls | 9. | INTC covered calls | 4. | RCAT covered calls | |
| 5. | IBIT covered calls | 10. | QQQ covered calls | 5. | QUBT covered calls | |
Want more examples? BPI Covered Calls | BPOP Covered Calls
